QA: Kura Oncology Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2019_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001422143')"}

Graph

Absolute values for 0001422143, Kura Oncology Inc.

  xvar xval
0 AssetsCurrent 181,197,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,182,000
4 LiabilitiesCurrent 13,615,000
5 LiabilitiesNoncurrent 7,779,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 62,883,000
11 remainder_Revenues 0
12 remainder_NetIncome 2,436,000
13 remainder_ComprehensiveNetIncome -82,000
  yvar yval
0 Assets 182,379,000
1 Liabilities 21,394,000
2 Expenses 62,883,000
3 Revenues 0
4 StockholdersEquity 160,985,000
5 NetIncome -60,447,000
6 ComprehensiveNetIncome -60,488,000
7 BaseVar 134,587,000
8 EconomicCapitalRatio 2.12

Edgar->Model Mapping

Feature Distribution

Change over Time